A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2006
11/22/2006	CN1285337C Application of Japanese raspberry saponin in the treatment of cerebral ischemia disease
11/22/2006	CN1285334C Application of pinocembrin in preparing medication for treating disease relevant to hurt of nerve cell
11/22/2006	CN1285332C Ginkgo keto-ester soft capsules with long stable effect and preparation thereof
11/21/2006	US7138543 Thiolalkyl benzoic acid derivatives
11/21/2006	US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
11/21/2006	US7138430 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/21/2006	US7138429 Flavonoid compound and process for producing the same
11/21/2006	US7138427 Cognition activators
11/21/2006	US7138426 Estrogen receptor modulators
11/21/2006	US7138425 Phthalimide carboxylic acid derivatives
11/21/2006	US7138424 Indole derivatives, method for preparing same and pharmaceutical compositions containing same
11/21/2006	US7138418 Pentafluorobenzenesulfonamides and analogs
11/21/2006	US7138417 Inhibitors of integrin αvβ6
11/21/2006	US7138416 Compounds and therapeutic uses thereof
11/21/2006	US7138415 Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
11/21/2006	US7138410 Aza-bicyclic N-biarylamides with affinity for the α7 nicotinic acetylcholine receptor
11/21/2006	US7138409 Heterocyclic compounds
11/21/2006	US7138404 Anxiolytic agents and analgesics
11/21/2006	US7138403 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity
11/21/2006	US7138399 2-[2-(4-alkoxypyridin-2-yl)alkyl])-3H-imidazo[4,5-b]pyridine derivatives and 8-[2-(4-alkoxypyridin-2-yl)alkyl])-9H-purine derivatives; used to treat an acute inflammatory disease in which the activity of inducible NO-synthase is involved
11/21/2006	US7138398 Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
11/21/2006	US7138390 3 alpha ,7 alpha -dihydroxy-6 alpha -ethyl-5 beta -cholan-24-oic acid and salts, solvates or amino acid conjugates thereof; treatment of a farnesoid X receptor mediated disease such as hypercholesteremia, hyperlipidemia, low HDL-cholesterol, and high triglycerides
11/21/2006	US7138379 Use of the interferon receptor 2c polypeptide chain to enhance the anti-growth effects of type I interferons
11/21/2006	US7138375 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138275 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138143 Coated preparation soluble in the lower digestive tract
11/21/2006	US7138116 Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
11/21/2006	US7138106 Compositions for use in embolizing blood vessels
11/21/2006	CA2334843C Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
11/21/2006	CA2334718C Quinoline derivatives
11/21/2006	CA2168022C Vasoconstrictive substituted dihydropyranopyridines
11/21/2006	CA2126518C Use of phenalkylamines
11/18/2006	CA2547251A1 Fused pyrazolyl compounds for cancer treatment
11/16/2006	WO2006122254A2 Stable micronized candesartan cilexetil and methods for preparing thereof
11/16/2006	WO2006122154A2 Pyridone derivatives for modulating stress-activated protein kinase system
11/16/2006	WO2006122047A1 Cardiovascular disease therapies
11/16/2006	WO2006121684A2 Acyl hydrazones for treating cardiovascular diseases
11/16/2006	WO2006120915A1 Agent for improving circulatory disorder
11/16/2006	WO2006120552A2 ANHYDROUS CRYSTALLINE FORMS OF N-[1-(2-ETHOXYETHYL)-5-(N-ETHYL-N-METHYLAMINO)-7-(4-METHYLPYRIDIN-2-yl-AMINO)-1H-PYRAZOLO[4,3-d]PYRIMIDINE-3-CARBONYL]METHANESULFONAMIDE
11/16/2006	WO2006120472A2 Novel beta-steroid compounds
11/16/2006	WO2006120160A1 Use of an immunoglobulin domain-containing cell surface recognition molecule for treating diseases
11/16/2006	WO2006119736A2 Pdz-domain modulators
11/16/2006	WO2006119692A1 A medicament for the treatment of hypertension
11/16/2006	WO2006119643A1 Anti-ocular angiogenesis molecules and their uses
11/16/2006	WO2006093348A3 Method and composition for treating peripheral vascular diseases
11/16/2006	WO2006083924A8 1-acylamino-2-hydroxy-3-amino-w-arylalkanes as renin inhibitors
11/16/2006	WO2006081517A3 Embolization using poly-4-hydroxybutyrate particles
11/16/2006	WO2005048977A3 Therapeutic foam comprising a sclerosing solution
11/16/2006	WO2004091614A8 Stabilized amlodipine maleate formations
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258731 Antitumor compound and therapeutic uses thereof
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258701 glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus; 3-(4-methoxy-phenylsulfanyl)-6-(4H-[1,2,4]triazol-3-yl-sulfanyl)-N-([1,3,4]thiadiazol-2-yl)-2-pyridine carboxamide
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258683 Para-sulfonyl substituted phenyl compounds as modulators of ppars
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258658 Triazole compounds useful as protein kinase inhibitors
11/16/2006	US20060258652 Beta-blockers having antioxidant and no-donor activity
11/16/2006	US20060258648 9-Azabicyclo'3.3.1 inon-6-ee derivatives with a heteroatom at the 3-position as renin inhibitors
11/16/2006	US20060258637 Fused polycyclic compounds
11/16/2006	US20060258632 Methods and agents for treating cardiovascular diseases
11/16/2006	US20060258585 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/16/2006	US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water
11/16/2006	US20060257989 Truncated aggrecanase molecules
11/16/2006	US20060257965 Extracellular matrix signalling molecules
11/16/2006	US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders
11/16/2006	US20060257882 Novel polynuceotides and polypeptides encoded thereby
11/16/2006	US20060257875 Affinity screening using "one-bead-one-compound" libraries
11/16/2006	US20060257843 Kappa-PVIIA-related conotoxins as organ protectants
11/16/2006	US20060257540 safflower seed extract prepared by washing a defatted safflower seed with water to obtain a washed product, separating the washed product from a resulting washing liquid, and extracting the washed product with an organic solvent; for reducing risk of developing atherosclerosis
11/16/2006	US20060257427 Molecule (antibody, peptide or chemical), coupled to a detectable label, cytotoxic agent or solid support, that specifically binds an extracellular portion of the latent viral membrane bound protein of Epstein-Barr Virus expressed in the latent viral membrane in the latent life cycle
11/16/2006	US20060257384 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
11/16/2006	DE102005061948A1 Verbessertes Verfahren zur Herstellung von 4'-O-Methylpyridoxin- und/oder Biflavon-armen Ginkgoextrakten An improved process for the preparation of 4'-O-Methylpyridoxin- and / or biflavone poor Ginkgo extracts
11/16/2006	DE102005023301A1 Medicament used to reduce risk of e.g. heart disease and urinary tract disease, comprises 5-methyl-(6S)-tetrahydrofolate, estrogen and/or gestagene, vitamin B6 and/or vitamin B2 and auxiliary or carrier materials
11/16/2006	DE102005023155A1 Albuminlösung Albumin solution
11/16/2006	CA2608243A1 Acyl hydrazones for treating cardiovascular diseases
11/16/2006	CA2608116A1 Method of modulating stress-activated protein kinase system
11/16/2006	CA2607044A1 Cardiovascular disease therapies
11/16/2006	CA2606778A1 Vascular disease therapies
11/15/2006	EP1721904A1 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
11/15/2006	EP1721903A1 Compositions and therapeutic methods involving isoflavones and analogues thereof
11/15/2006	EP1721610A1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative
11/15/2006	EP1721608A2 Upregulation of type III endothelial cell nitric oxide synthase by HMG-CoA reductase inhibitors
11/15/2006	EP1720984A1 Methods and compositions for treatment or prevention of secondary ischemic injury
11/15/2006	EP1720889A1 Sulfated oligosaccharide derivatives
11/15/2006	EP1720850A1 Coumarin derivative and use thereof
11/15/2006	EP1720844A2 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
11/15/2006	EP1720552A2 Methods for treating inflammatory and autoimmune diseases
11/15/2006	EP1720549A1 Kv1.5-blocker for the selective increase of atrial contractility and treatment of cardiac insufficiency
11/15/2006	EP1599198B1 Potassium taurate bicarbonate and ascorbate complexes
11/15/2006	EP1539746B1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
11/15/2006	EP1495111A4 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
11/15/2006	EP1453511B1 Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
11/15/2006	EP1427718B1 Benzothiepine ileal bile acid transport inhibotors
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1416927B1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect
11/15/2006	EP1411881B9 5ht2c receptor modulators

1 ... 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 ... 1595